The anti-inflammatory cytokine-transforming growth factor-β (TGF-β) and IFN-β have been implied in polarizing tumor-associated neutrophils toward an antitumorigenic and antiangiogenic phenotype (215, 216). The gene discussed is IFNB1; the disease is neoplasm.